CN116874576B - 一种重组人源化丝聚蛋白及其制备方法和应用 - Google Patents
一种重组人源化丝聚蛋白及其制备方法和应用 Download PDFInfo
- Publication number
- CN116874576B CN116874576B CN202310770727.7A CN202310770727A CN116874576B CN 116874576 B CN116874576 B CN 116874576B CN 202310770727 A CN202310770727 A CN 202310770727A CN 116874576 B CN116874576 B CN 116874576B
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- recombinant
- recombinant humanized
- pichia pastoris
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims abstract description 20
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 20
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000013598 vector Substances 0.000 claims description 31
- 241000235058 Komagataella pastoris Species 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 230000014509 gene expression Effects 0.000 claims description 25
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- 108091008146 restriction endonucleases Proteins 0.000 claims description 16
- 230000003248 secreting effect Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 238000001976 enzyme digestion Methods 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 238000010276 construction Methods 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 108020004705 Codon Proteins 0.000 claims description 4
- 241001506991 Komagataella phaffii GS115 Species 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 108010076039 Polyproteins Proteins 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 239000000178 monomer Substances 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 230000008591 skin barrier function Effects 0.000 abstract description 6
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 24
- 102100028314 Filaggrin Human genes 0.000 description 23
- 101710088660 Filaggrin Proteins 0.000 description 23
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 14
- 210000000434 stratum corneum Anatomy 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 239000012634 fragment Substances 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 8
- 102000037865 fusion proteins Human genes 0.000 description 7
- 108020001507 fusion proteins Proteins 0.000 description 7
- 108700041153 Filaggrin Proteins Proteins 0.000 description 6
- 108010076876 Keratins Proteins 0.000 description 6
- 102000011782 Keratins Human genes 0.000 description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 108010084455 Zeocin Proteins 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 4
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 4
- 230000036572 transepidermal water loss Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000040739 Secretory proteins Human genes 0.000 description 3
- 108091058545 Secretory proteins Proteins 0.000 description 3
- 108010013296 Sericins Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- LOIYMIARKYCTBW-UPHRSURJSA-N cis-urocanic acid Chemical compound OC(=O)\C=C/C1=CNC=N1 LOIYMIARKYCTBW-UPHRSURJSA-N 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 102100036826 Aldehyde oxidase Human genes 0.000 description 2
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 2
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108010025544 Bleomycin hydrolase Proteins 0.000 description 1
- 102100027058 Bleomycin hydrolase Human genes 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 102000003895 Calpain-1 Human genes 0.000 description 1
- 108090000236 Calpain-1 Proteins 0.000 description 1
- 102000004958 Caspase-14 Human genes 0.000 description 1
- 108090001132 Caspase-14 Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 101001091379 Homo sapiens Kallikrein-5 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100034868 Kallikrein-5 Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 108010091175 Matriptase Proteins 0.000 description 1
- 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 102100033717 Retroviral-like aspartic protease 1 Human genes 0.000 description 1
- 101710184461 Retroviral-like aspartic protease 1 Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000617 superantigen Toxicity 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43586—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/84—Pichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Birds (AREA)
- Insects & Arthropods (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310770727.7A CN116874576B (zh) | 2023-06-28 | 2023-06-28 | 一种重组人源化丝聚蛋白及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310770727.7A CN116874576B (zh) | 2023-06-28 | 2023-06-28 | 一种重组人源化丝聚蛋白及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116874576A CN116874576A (zh) | 2023-10-13 |
CN116874576B true CN116874576B (zh) | 2024-03-12 |
Family
ID=88265372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310770727.7A Active CN116874576B (zh) | 2023-06-28 | 2023-06-28 | 一种重组人源化丝聚蛋白及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116874576B (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1535723A (zh) * | 2003-02-28 | 2004-10-13 | ������������ũҵ������Դ�о��� | 来源于丝蛋白的促细胞生长肽的提取与应用 |
JP2008245623A (ja) * | 2007-03-30 | 2008-10-16 | Hiroshima Industrial Promotion Organization | 改変フィブロインを生産する遺伝子改変カイコ |
CN101906420A (zh) * | 2010-01-29 | 2010-12-08 | 浙江省台州医院 | 人聚角微丝蛋白基因原核表达系统及其表达蛋白的应用 |
CN102321650A (zh) * | 2011-06-27 | 2012-01-18 | 苏州大学 | 一种利用转基因家蚕生产荧光抗菌丝的方法 |
CN111494712A (zh) * | 2020-05-12 | 2020-08-07 | 尧舜泽生物医药(南京)有限公司 | 一种融合有nt3的丝素蛋白神经移植物的制备方法 |
CN111777685A (zh) * | 2020-07-12 | 2020-10-16 | 南通大学 | 一种融合有vegf的丝素蛋白移植物及其制备方法 |
CN112236153A (zh) * | 2018-04-05 | 2021-01-15 | 阿兹特拉公司 | 用重组微生物治疗皮肤疾病的方法和组合物 |
CN113045638A (zh) * | 2021-04-01 | 2021-06-29 | 芜湖英特菲尔生物制品产业研究院有限公司 | 一种酿酒酵母表达长效重组人丝聚蛋白及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0525492D0 (en) * | 2005-12-15 | 2006-01-25 | Univ Dundee | Filaggrin |
ES2664591T3 (es) * | 2009-09-25 | 2018-04-20 | Curna, Inc. | Tratamiento de enfermedades relacionadas con la filagrina (flg) mediante la modulación de la expresión y actividad del gen FLG |
-
2023
- 2023-06-28 CN CN202310770727.7A patent/CN116874576B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1535723A (zh) * | 2003-02-28 | 2004-10-13 | ������������ũҵ������Դ�о��� | 来源于丝蛋白的促细胞生长肽的提取与应用 |
JP2008245623A (ja) * | 2007-03-30 | 2008-10-16 | Hiroshima Industrial Promotion Organization | 改変フィブロインを生産する遺伝子改変カイコ |
CN101906420A (zh) * | 2010-01-29 | 2010-12-08 | 浙江省台州医院 | 人聚角微丝蛋白基因原核表达系统及其表达蛋白的应用 |
CN102321650A (zh) * | 2011-06-27 | 2012-01-18 | 苏州大学 | 一种利用转基因家蚕生产荧光抗菌丝的方法 |
CN112236153A (zh) * | 2018-04-05 | 2021-01-15 | 阿兹特拉公司 | 用重组微生物治疗皮肤疾病的方法和组合物 |
CN111494712A (zh) * | 2020-05-12 | 2020-08-07 | 尧舜泽生物医药(南京)有限公司 | 一种融合有nt3的丝素蛋白神经移植物的制备方法 |
CN111777685A (zh) * | 2020-07-12 | 2020-10-16 | 南通大学 | 一种融合有vegf的丝素蛋白移植物及其制备方法 |
CN113045638A (zh) * | 2021-04-01 | 2021-06-29 | 芜湖英特菲尔生物制品产业研究院有限公司 | 一种酿酒酵母表达长效重组人丝聚蛋白及其应用 |
Non-Patent Citations (4)
Title |
---|
Construction of transgenic silkworm gene targeting vectors based on fibroin light chain.;Zhu Chenggang et al.;《Journal of Agricultural Biotechnology》;第10卷(第2期);全文 * |
Functionalized silk fibers from transgenic silkworms for wound healing applications: Surface presentation of bioactive epidermal growth factor.;Woltje, M. et al.;《Journal of Biomedical Materials Research Part A》;第106卷(第10期);全文 * |
家蚕丝素蛋白轻链基因(fib-L)启动子序列的克隆及其活性分析;周文林等;《昆虫学报》;20070620(第06期);全文 * |
现代盐化工;汪涛等;《现代盐化工》;第48卷(第5期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN116874576A (zh) | 2023-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102559311B1 (ko) | 재조합 인간 xvii형 콜라겐, 제조방법 및 응용 | |
Chua et al. | High-frequency binding of IgE to the Der p allergen expressed in yeast | |
JPS63276491A (ja) | PA1−2と命名されるArg−セルピン・ヒトプラスミノーゲン活性化物質の抑制剤 | |
JPH09103295A (ja) | 形質転換酵母によるヒルジンの発現及び抗凝血剤組成物 | |
CN113621053A (zh) | 一种重组人源胶原蛋白及其制备方法和应用 | |
CN111454350A (zh) | 一种重组纤连蛋白突变体及其应用 | |
CN113527523B (zh) | 一种重组蛋白及其构建方法和用途 | |
CN116874576B (zh) | 一种重组人源化丝聚蛋白及其制备方法和应用 | |
CN106632664A (zh) | 载脂蛋白ii/i及其制备方法、生物学功能及应用 | |
EP0587541B1 (en) | Process to purify the big-endothelin protein | |
CN116554309A (zh) | 一种重组人源ⅲ型胶原蛋白及其制备方法和应用 | |
DE69837507T2 (de) | Humanes Hedgehog-Protein | |
CN107904251B (zh) | TAT-hEGF融合蛋白的制备及其在隐形面膜的应用 | |
CN115109795B (zh) | 重组人源iii型胶原蛋白注射剂及其在皮肤胶原再生中的应用 | |
CN113527525B (zh) | 重组蛋白及其构建方法、用途 | |
EP2143790B1 (en) | A purified recombinant batroxobin with high specific activity | |
US6255067B1 (en) | cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) | |
CN109081870A (zh) | 一种抗人促绒毛膜促性腺激素β亚单位的纳米抗体及核酸分子和应用 | |
EP0240224A2 (en) | An alpha interferon analogue | |
CN113527524A (zh) | 重组蛋白及其构建方法和用途 | |
JP2561149B2 (ja) | 機能性ポリペプチド | |
CN113527526B (zh) | 一种重组蛋白及其构建方法、用途 | |
CN108484738B (zh) | 辐抗肽突变蛋白及其制备与纯化方法 | |
KR101135648B1 (ko) | 소 유래 신규 Hyal 5 유전자 및 이를 이용한 소 정자의 수정능 판별방법 | |
JP2623807B2 (ja) | セリンプロテアーゼおよびセリンプロテアーゼ遺伝子 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240529 Address after: Room 1501, Floor 15, Pisces, No. 53, Middle Section of Mount Huangshan Avenue, Dazhulin Street, Liangjiang New District, Yubei District, Chongqing 400000 (cluster registration) Patentee after: Chongqing Jimei Technology Co.,Ltd. Country or region after: China Address before: 13-3, No. 5 Fengtian Avenue, Shapingba District, Chongqing, 400000 Patentee before: Hu Rongyang Country or region before: China Patentee before: Zhu Like |